Drug Restores Hair Growth in Patients with Alopecia Areata (video) Columbia University Medical Center Share Print E-Mail Loading video... Caption Seventy-five percent of patients with moderate to severe alopecia areata--an autoimmune disease that causes patchy and, less frequently, total hair loss--had significant hair regrowth after treatment with ruxolitinib, reported researchers from Columbia University Medical Center (CUMC). By the end of their treatment, average hair regrowth was 92 percent. Youtube link for embedding: https://www.youtube.com/watch?v=01woTEx3gqI Read more: http://newsroom.cumc.columbia.edu/blog/2016/09/22/drug-restores-hair-growth-in-patients-with-alopecia-areata/ Credit Columbia University Medical Center Usage Restrictions None Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.